| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 2 buys and 19 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2020 | Cha Albert | Director | Buy | 115,686 | $17.24 | $1,994,067.74 | +5.5% | |
| Oct 29, 2020 | Yea Christopher53 | Chief Development Officer | Sell | 5,000 | $17.48 | $87,394.00 | -7.4% | |
| Oct 21, 2020 | Yea Christopher53 | Chief Development Officer | Sell | 13,986 | $17.82 | $249,167.38 | -4.6% | |
| Oct 21, 2020 | Crockett Thomas Andrew72 | CEO | Sell | 38,539 | $17.98 | $693,025.16 | -3.5% | |
| Oct 21, 2020 | Feener Edward P.72 | Chief Scientific Officer | Sell | 16,907 | $17.92 | $303,018.60 | -4.7% | |
| Oct 16, 2020 | Yea Christopher53 | Chief Development Officer | Sell | 914 | $17.00 | $15,539.28 | -1.1% | |
| Oct 16, 2020 | Feener Edward P.72 | Chief Scientific Officer | Sell | 993 | $17.00 | $16,881.00 | -1.0% | |
| Oct 16, 2020 | Crockett Thomas Andrew72 | CEO | Sell | 1,261 | $17.01 | $21,444.06 | -0.5% | |
| Feb 5, 2020 | Yea Christopher53 | Chief Development Officer | Sell | 100 | $17.10 | $1,710.00 | -0.1% | |
| Feb 5, 2020 | Feener Edward P.72 | Chief Scientific Officer | Sell | 100 | $17.11 | $1,711.00 | -0.1% |